Correlation between clinical and pathological staging in resectable NSCLC - analysis on 360 surgical cases

D. Subotic, D. Mandaric, G. Radosavljevic, V. Cemerikic, L. Andric (Belgrade, Yugoslavia)

Source: Annual Congress 2001 - Bronchial carcinoma and mediastinal tumours
Session: Bronchial carcinoma and mediastinal tumours
Session type: Thematic Poster Session
Number: 885
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Subotic, D. Mandaric, G. Radosavljevic, V. Cemerikic, L. Andric (Belgrade, Yugoslavia). Correlation between clinical and pathological staging in resectable NSCLC - analysis on 360 surgical cases. Eur Respir J 2001; 16: Suppl. 31, 885

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Usefulness of surgical staging after negative EBUS -staging in patients with lung cancer with clinical N0.
Source: International Congress 2019 – General thoracic surgery
Year: 2019

Comparison of clinical and pathological/surgical TNM staging of NSCLC
Source: Eur Respir J 2003; 22: Suppl. 45, 254s
Year: 2003

The relation between clinical tumor stage and metastasis according to sixth TNM staging and new revised TNM staging in non-small lung cancer patients
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease?
Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018
Year: 2019



Comparative diagnostic accuracy of thoracic endosonography (EBUS/EUS-b) and integrated PET-CT in mediastinal staging of potentially operable patients with NSCLC.
Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound
Year: 2020


Comparative evaluation of resectability, postoperative morbidity and mediastinal downstaging after cisplatin-based chemoinduction versus radiochemoinduction for stage III non-small cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 214s
Year: 2003

Comparison of the new and current TNM staging system in bronchoplastic resection for non-small cell lung cancer
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010


Complete endosonographic nodal staging of lung cancer in patients eligible for stereotactic ablative radiotherapy (STAGE study NCT02997449)
Source: International Congress 2017 – Interventional pulmonology highlights 2017
Year: 2017



Occult N2 disease after surgical resection for clinical stage I NSCLC: factors affecting survival
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

Survival of patients after complete surgical resection in NSCLC stage IV with solitary metastases
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010

Contribution of FDG-PET on staging and management of NSCLC planned for concomitant chemoradiotherapy
Source: Eur Respir J 2007; 30: Suppl. 51, 664s
Year: 2007

Clinical value of 18-FDG PET-CT in mediastinal lymph node staging in non-small cell lung cancer (NSCLC) patients with previous cN0-1 on CT
Source: Annual Congress 2007 - Diagnosis of thoracic malignancies
Year: 2007


An audit of prognostic significance of histological subtype in surgically resected adenocarcinomas
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016

Concurrent WBBS and FDG-PET and primary staging of NSCLC, a retrospective analysis
Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities
Year: 2009



Prognostic value of SUVmax in patients with lung cancer who underwent surgical treatment
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012


The comparison of the findings of preoperative PET-CT and surgical pathology in patients with non-small cell lung cancer those with and without induction therapy
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011

Staging and restaging in the era of multimodality treatment
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Surgical treatment of lung cancer after polyhemothetapy/radiotherapy down-staging in patients initially assessed as inoperable
Source: Eur Respir J 2006; 28: Suppl. 50, 718s
Year: 2006

Contribution of tumor markers to pretreatment staging of operable lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 360s
Year: 2003

Evaluate of radiological, bronchoscopical and histopathological features of patients with primary lung cancer
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008